1. Home
  2. HUBC vs RDHL Comparison

HUBC vs RDHL Comparison

Compare HUBC & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hub Cyber Security Ltd.

HUBC

Hub Cyber Security Ltd.

HOLD

Current Price

$0.40

Market Cap

25.0M

Sector

N/A

ML Signal

HOLD

Logo Redhill Biopharma Ltd.

RDHL

Redhill Biopharma Ltd.

HOLD

Current Price

$1.06

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUBC
RDHL
Founded
2017
2009
Country
Israel
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.0M
5.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HUBC
RDHL
Price
$0.40
$1.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.7M
71.8K
Earning Date
05-01-2026
09-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$28,966,000.00
$9,550,000.00
Revenue This Year
N/A
$381.91
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
157.62
52 Week Low
$0.32
$0.91
52 Week High
$14.00
$6.80

Technical Indicators

Market Signals
Indicator
HUBC
RDHL
Relative Strength Index (RSI) 29.52 38.43
Support Level $0.35 $0.91
Resistance Level $0.44 $1.23
Average True Range (ATR) 0.07 0.07
MACD 0.03 -0.01
Stochastic Oscillator 34.51 46.21

Price Performance

Historical Comparison
HUBC
RDHL

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

Share on Social Networks: